Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]
The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]
On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]
The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]
International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the […]
The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new […]
This measure allows for greater participation and the inclusion of a more diverse population, which improves the scientific quality of the studies, as highlighted by Farmaindustria’s […]
In the opinion of the employers’ association, it “represents yet another barrier to patient access to innovative treatments” Source: espaciosanitario.com Following the proposed revision of the […]
Farmaindustria brings together in Spain the main European National Associations representing the innovative pharmaceutical industry and the European Federation of the Pharmaceutical Industry together with the […]
Farmaindustria states that it is “the first sectoral code approved by the AEPD and a reference at European level” Source: espaciosanitario.com Farmaindustria has announced that a […]
Source: elperiodico.com Multiple sclerosis is an autoimmune disease of the central nervous system that affects the brain and spinal cord. It is caused by damage to […]